James Strickland
Pulmonary Disease · Birmingham, ALNPI 1548201601
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $641 and has fallen 76.9% since, to $148 in 2022. That places this record below the midpoint for pulmonary disease clinicians in AL, where the typical reported total is $3,082.
Across 82 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$206
- GSK$200
- Philips North America LLC$187
- Takeda Pharmaceuticals U.S.A., Inc.$180
- Genentech USA, Inc.$141
- Mallinckrodt Enterprises LLC$71
- plus $443 from 15 others
What the payments were for
- Food & beverage$1,40598%
- Entertainment$222%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $206 |
| GSK | 14 | $200 |
| Philips North America LLC | 9 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $180 |
| Genentech USA, Inc. | 8 | $141 |
| Mallinckrodt Enterprises LLC | 3 | $71 |
| Boehringer Ingelheim | 4 | $65 |
| Insmed, Inc. | 4 | $59 |
| Pfizer | 3 | $50 |
| Jazz Pharmaceuticals Inc. | 2 | $44 |
| Mylan Specialty L.p. | 2 | $32 |
| Johnson & Johnson | 2 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
| Cook Medical LLC | 2 | $23 |
| Itamar Medical Inc | 1 | $22 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| AbbVie | 1 | $16 |
| Gilead | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$1,427 in reported general payments places this provider in the 40th percentile of 215 pulmonary disease providers in Alabama.
Other pulmonary disease in Birmingham
- Tejaswini KulkarniBirmingham$134K
- Amanda DenhamBirmingham$45K
- Bryan GarciaBirmingham$29K
- Steven RoweBirmingham$27K
- Peter MorrisBirmingham$25K
- Russell BeatyBirmingham$24K
- Jay HeideckerBirmingham$21K
- Jennifer TrevorBirmingham$19K
- Jason FainBirmingham$18K
- Jeffrey GarnerBirmingham$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.